Login / Signup
Mohammed Zafaryab
(Mohammad ZafarYab)
ORCID
Publication Activity (10 Years)
Years Active: 2018-2024
Publications (10 Years): 6
Top Topics
Cancer Therapy
Drug Delivery
Reduced Graphene Oxide
Signaling Pathway
Top Venues
Nanomedicine (London, England)
ACS applied bio materials
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Karishma Niveria
,
Mohammed Zafaryab
,
Largee Biswas
,
Asiya Mahtab
,
Anita Kamra Verma
Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells.
Nanomedicine (London, England)
19 (10) (2024)
Karishma Niveria
,
Mohammed Zafaryab
,
Largee Biswas
,
Asiya Mahtab
,
Anita Kamra Verma
Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells.
Nanomedicine (London, England)
19 (10) (2024)
Karishma Niveria
,
Mohammed Zafaryab
,
Largee Biswas
,
Asiya Mahtab
,
Anita Kamra Verma
Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells.
Nanomedicine (London, England)
19 (10) (2024)
Karishma Niveria
,
Mohammed Zafaryab
,
Largee Biswas
,
Asiya Mahtab
,
Anita Kamra Verma
Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells.
Nanomedicine (London, England)
(2024)
Karishma Niveria
,
Mohammed Zafaryab
,
Largee Biswas
,
Asiya Mahtab
,
Anita Kamra Verma
Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells.
Nanomedicine (London, England)
19 (10) (2024)
Rabia Kouser
,
Arti Vashist
,
Mohammed Zafaryab
,
Moshahid A Rizvi
,
Sharif Ahmad
pH-Responsive Biocompatible Nanocomposite Hydrogels for Therapeutic Drug Delivery.
ACS applied bio materials
1 (6) (2018)